Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001494743 | SCV001699406 | likely benign | Hypertrophic cardiomyopathy | 2023-04-12 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002439187 | SCV002753755 | likely benign | Cardiovascular phenotype | 2020-10-13 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
CHEO Genetics Diagnostic Laboratory, |
RCV003150438 | SCV003837691 | likely benign | Cardiomyopathy | 2021-10-08 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV003150438 | SCV004359905 | likely benign | Cardiomyopathy | 2021-10-21 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV001494743 | SCV004819080 | likely benign | Hypertrophic cardiomyopathy | 2023-11-30 | criteria provided, single submitter | clinical testing |